HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endoscopic application of dextranomer/hyaluronic acid copolymer in the treatment of vesico-ureteric reflux after renal transplantation.

AbstractOBJECTIVE:
• To evaluate the success of endoscopic dextranomer/hyaluronic acid copolymer (DHAC) application in the treatment of patients with recurrent urinary tract infections (UTIs) and vesico-ureteric reflux (VUR) into the transplanted graft after renal transplantation.
PATIENTS AND METHODS:
• Between January 2008 and April 2009, 19 patients with recurrent UTIs presented VUR proven by voiding cystourethrography. • To correct VUR of the transplanted ureter, DHAC was injected endoscopically using hydrodistention technique. • Pre- and postoperative serum creatinine levels, the number of pre- and postoperative UTIs, postoperative complications and reflux resolution rate were recorded. The mean follow-up was 6.5 months.
RESULTS:
• The average number of UTIs was reduced significantly from 4.89 (range 2-14) to 1.31 (range 0-4) on pre- and postoperative follow-up, respectively, of 6 months (P < 0.001). The success rate increased from 57.9% after the first injection to 78.9% after the second injection. • The remaining four patients with residual VUR received long-term low dose antibiotic prophylaxis. In total, two (10.5%) patients developed increasing creatinine levels postoperatively as a result of distal ureteral obstruction, and temporary urinary drainage was necessary in both patients.
CONCLUSIONS:
• DHAC appears to be an efficient and minimal invasive method for treating VUR after renal transplantation with respect to short-term success. • Further investigation with a larger group of patients and longer follow-up is needed to evaluate the prolonged effect, as well as any potential side effects.
AuthorsRenate Pichler, Alexander Buttazzoni, Peter Rehder, Georg Bartsch, Hannes Steiner, Josef Oswald
JournalBJU international (BJU Int) Vol. 107 Issue 12 Pg. 1967-72 (Jun 2011) ISSN: 1464-410X [Electronic] England
PMID21059169 (Publication Type: Evaluation Study, Journal Article)
Copyright© 2010 THE AUTHORS. BJU INTERNATIONAL © 2010 BJU INTERNATIONAL.
Chemical References
  • Biocompatible Materials
  • Dextrans
  • dextranomer-hyaluronic acid copolymer
  • Hyaluronic Acid
Topics
  • Adult
  • Aged
  • Biocompatible Materials (administration & dosage)
  • Dextrans (administration & dosage)
  • Female
  • Humans
  • Hyaluronic Acid (administration & dosage)
  • Kidney Transplantation (adverse effects)
  • Male
  • Middle Aged
  • Retrospective Studies
  • Secondary Prevention
  • Treatment Outcome
  • Ureteroscopy
  • Urinary Tract Infections (etiology, prevention & control)
  • Vesico-Ureteral Reflux (etiology, therapy)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: